9p21.3 risk locus is associated with first-ever myocardial infarction in an Austrian cohort
Authors:
- Helmuth HaslacherHHHelmuth Haslacher
- Thomas PerkmannTPThomas Perkmann
- Franz RatzingerFRFranz Ratzinger
- Gabriele GrimmGGGabriele Grimm
- Markus ExnerMEMarkus Exner
- Alexandra KellerAKAlexandra Keller
- Klaus SchmettererKSKlaus Schmetterer
- Clemens PriemerCPClemens Priemer
- Georg EndlerGEGeorg Endler
- Oswald WagnerOWOswald Wagner
- Martin SchillingerMSMartin Schillinger
- 1 August 2016
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 17 (8) , 595-600
Abstract
Y processes. We thus aimed to replicate the predictive value of genetic information on this variant regarding the development of cardiovascular events in an Austrian high-risk cohort. Methods Nine hundred and eighty-eight patients from an angiologic outpatient ward at a large University hospital were genotyped by means of the 5’-nuclease assay. Relative risk ratios were assessed for carriers of different alleles. Statistical independence of genetic information was evaluated in multivariable analysis including known risk markers. Results In patients carrying the [G]-allele, metabolic parameters (serum low-density lipoprotein, total cholesterol) significantly decreased during the initial 6 months of the observation period (P < 0.01). Likewise, homozygous [C]-allele carriers were at a higher risk of suffering myocardial infarction (relative risk = 2.681, 95% confidence interval 1.418–5.070). In contrast, we found no interaction between rs1333049 genotype and progression of carotid atherosclerosis or stroke. Conclusions These results are in line with the previous findings, suggesting that genetic information on the rs1333049 variant might be a useful predictor of adverse cardiac events. Thus, we could successfully replicate the predictive value of the 9p21 risk allele in an Austrian cohort....Keywords
This publication has 24 references indexed in Scilit:
- CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMCBiochemical and Biophysical Research Communications, 2012
- Influence of 9p21.3 Genetic Variants on Clinical and Angiographic Outcomes in Early-Onset Myocardial InfarctionJACC, 2011
- Association of polymorphisms in 9p21 region with CAD in North Indian population: replication of SNPs identified through GWASClinical Genetics, 2010
- Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk LocusArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery DiseaseCirculation, 2008
- Genomewide Association Analysis of Coronary Artery DiseaseNew England Journal of Medicine, 2007
- A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial InfarctionScience, 2007
- Genetics and heritability of coronary artery disease and myocardial infarctionClinical Research in Cardiology, 2006
- Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS)Circulation, 2005
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994